San Diego, CA \u2013 July 25, 2016<\/b> \u2013 <\/span>Medical Marijuana, Inc.\u2019s <\/span>(OTC: MJNA) management team today announced that it has named Dion Markgraaff as President of its subsidiary <\/span>HempMeds\u00ae Mexico<\/span><\/a>, effective August 3, 2016. <\/span><\/p>\n With more than 25 years of experience in the cannabis industry, Mr. Markgraaff will help drive the sales, marketing and distribution of <\/span>HempMeds\u00ae Mexico<\/span><\/a>\u2018s non-psychoactive, THC-free hemp-based cannabidiol (CBD) product <\/span>Real Scientific Hemp Oil-X\u2122<\/span><\/a> (RSHO-X\u2122) throughout Mexico. <\/span>RSHO-X\u2122<\/span><\/a> was the first-ever federally approved CBD product in Mexico, a country of 120 million residents that represents a significant potential market worth up to $12 billion annually. <\/span><\/p>\n \u201dWe are thrilled that Mr. Markgraaff will be heading up our <\/span>HempMeds\u00ae Mexico<\/span><\/a> subsidiary,\u201d said CEO of <\/span>Medical Marijuana, Inc.<\/span><\/a> Dr. Stuart Titus. \u201cMr. Markgraaff\u2019s extensive experience in working to revitalize the cannabis industry will be a tremendous asset as we continue working directly with the Mexican government to safely and legally provide access to CBD hemp oil products to the people of Mexico. In addition, Mr. Markgraaff will help us pursue our work to open up even greater access to our CBD-based products throughout the country, including developing additional ways to educate patients and health professionals on the plethora of medical marijuana\u2019s benefits. If full legalization of all cannabis products becomes a reality in Mexico, Mr. Markgraaff will help us be in the right position to bring out products quickly to market.\u201d<\/span><\/p>\n Prior to being named President of <\/span>HempMeds\u00ae Mexico<\/span><\/a>, Markgraaff served as a business development consultant for <\/span>General Hemp\u2122 LLC<\/span><\/a>, a private equity company founded to support growth in the industrial hemp industry. During this time, Markgraaff was instrumental in opening the Mexico cannabis market and introducing <\/span>RSHO-X\u2122<\/span><\/a> into the Country. He also helped <\/span>HempMeds\u00ae Mexico<\/span><\/a> solidify a partnership with Mexico\u2019s champion for cannabis reform Raul Elizalde and his <\/span>Por Grace Foundation<\/span><\/a>, the leading association fighting to ensure families receive the right to health care and medical access to CBD hemp oil in Mexico. <\/span>Elizalde\u2019s family was the first in Mexico to sue the federal government and win the right to import CBD hemp oil to treat their daughter Grace\u2019s severe form of epilepsy known as Lennox-Gastaux Syndrome. Through the combined efforts of <\/span>HempMeds\u00ae Mexico<\/span><\/a> and the <\/span>Por Grace Foundation<\/span><\/a>, including sponsoring and participating in multiple public forums like the <\/span>National Debates on Marijuana Use<\/span><\/a>, major changes have occurred in Mexico\u2019s marijuana policy. <\/span>On April 21, 2016, <\/span>Mexico’s President Enrique Pe\u00f1a Nieto announced at a conference, at which Elizalde also spoke, <\/span>his intent to move the country away from marijuana prohibition and towards science-based policies and human rights, including medicinal use.<\/span><\/p>\n During his career, Mr. Markgraaff has achieved many \u201cfirsts\u201d for the cannabis industry, as founder of Europe\u2019s first hemp store \u201cCannabis in Amsterdam\u201d in 1993; organizer of the first medical cannabis dispensary in San Diego in 1997; and founder of one of the largest cannabis patient rights groups San Diego Americans for Safe Access in 2002. Mr. Markgraaff also spent ten years of his career at Dr. Bronner\u2019s, the largest manufacturer of certified organic and fair trade soaps. Mr. Markgraaff graduated with a dual Bachelor of Arts and Science degree in Political Science and History from San Diego State University. <\/span><\/p>\n On Aug. 14 at 10:15 a.m. Markgraaff will introduce <\/span>HempMeds\u00ae Mexico<\/span><\/a> at the <\/span>ExpoWeed Conference<\/span><\/a> \u2013 the first-ever cannabis conference to be held in Mexico \u2013 which is taking place on Aug. 12-14 at the International Exhibitions and Conference World Trade Center in Mexico City. Markgraff will be joined by Elizalde and two of the first Mexico families to receive approval from the Mexican government to import <\/span>RSHO-X\u2122. \u00a0<\/span>Markgraaff will also partake in the press conference prior to the Expo on Aug. 10 at 10:00 a.m. at the World Trade Center. <\/span>HempMeds\u00ae Mexico<\/span><\/a> is a sponsor of the <\/span>ExpoWeed Conference<\/span><\/a> and will be exhibiting retail-ready cannabis products, including <\/span>its zero-THC <\/span>RSHO-X\u2122<\/span><\/a>, <\/span>the first-ever cannabis product to receive approval from the federal government of Mexico for importation.<\/span><\/p>\n RSHO-X\u2122<\/span><\/a> is also the first cannabis-based product to qualify as safe for World Anti-Doping standards and therefore could be safely used by Olympic athletes. \u00a0<\/span><\/p>\n ###<\/span> About HempMeds\u00ae Mexico<\/b><\/p>\n HempMeds<\/span><\/a>\u00ae<\/span> Mexico<\/span><\/a> is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X\u2122 for a medical indication. HempMeds\u00ae Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company\u2019s website at: <\/span>http:\/\/www.hempmeds.mx<\/span><\/a>.<\/span><\/p>\n About HempMeds\u00ae<\/b><\/p>\n HempMeds\u00ae offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds\u00ae is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink: MJNA) and the Company\u2019s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds\u00ae is the communication hub for the Medical Marijuana Inc. portfolio of companies.<\/span><\/p>\n About Real Scientific Hemp Oil\u2122<\/b><\/p>\n Real Scientific Hemp Oil\u2122 is a global headline-maker: The first cannabis product to receive federal government import permits from both the governments of Brazil and Mexico \u2013 now imported into Brazil for multiple medical indications and subsidized under the country\u2019s healthcare system. Formulated using Medical Marijuana, Inc.\u2019s state of the art and eco-friendly proprietary technologies, RSHO\u2122 is\u00a0the finest, most consistent and 100 percent natural CBD hemp-based cannabinoid oil in the world.<\/span><\/p>\n About Medical Marijuana, Inc.<\/b><\/p>\n Our mission is to be the premier cannabis and hemp industry innovators, leveraging our\u00a0team of professionals to source, evaluate and purchase value-added companies and\u00a0products, while allowing them to keep their integrity and entrepreneurial spirit. We strive\u00a0to create awareness within our industry, develop environmentally-friendly, economically\u00a0sustainable businesses, while increasing shareholder value. For details on\u00a0Medical\u00a0Marijuana, Inc.\u2019s portfolio and investment companies, visit\u00a0<\/span>www.medicalmarijuanainc.com<\/span><\/a>.<\/span><\/p>\n To see Medical Marijuana, Inc.\u2019s video statement,\u00a0<\/span>click here<\/span><\/a>.\u00a0Shareholders are also encouraged to visit the\u00a0<\/span>Medical Marijuana, Inc. Shop<\/span><\/a>\u00a0for\u00a0discounted products.<\/span><\/p>\n FORWARD-LOOKING DISCLAIMER<\/i><\/b><\/p>\n This press release may contain certain forward-looking statements and information, as\u00a0defined within the meaning of Section 27A of the Securities Act of 1933 and Section\u00a021E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created\u00a0by those sections. This material contains statements about expected future events\u00a0and\/or financial results that are forward-looking in nature and subject to risks and\u00a0uncertainties. Such forward-looking statements by definition involve risks, uncertainties\u00a0and other factors, which may cause the actual results, performance or achievements of\u00a0Medical Marijuana, Inc. to be materially different from the statements made herein.<\/span><\/i><\/p>\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/i><\/b><\/p>\n These statements have not been evaluated by the FDA and are not intended to\u00a0diagnose, treat or cure any disease.<\/span><\/i><\/p>\n LEGAL DISCLOSURE<\/i><\/b><\/p>\n Medical Marijuana Inc. does not sell or distribute any products that are in violation of the\u00a0United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution\u00a0of medical marijuana-based products within certain international markets. Cannabidiol is\u00a0a natural constituent of hemp oil.<\/span><\/i><\/p>\n \u00a0<\/b><\/p>\n Public Relations Contact:<\/b><\/p>\n Andrew Hard<\/span><\/p>\n Chief Executive Officer<\/span><\/p>\n CMW Media<\/span><\/p>\n 888-829- 0070<\/span><\/p>\n andrew.hard@cmwmedia.com<\/span><\/a><\/p>\n www.cmwmedia.com<\/span><\/a><\/p>\n \u00a0<\/span><\/p>\n Corporate Business Contact:<\/b><\/p>\n Nicholas R. Massalas<\/span><\/p>\n Director of Business Development<\/span><\/p>\n Medical Marijuana, Inc.<\/span><\/p>\n OTC Symbol: MJNA<\/span><\/p>\n Toll Free: 888-OTC- MJNA\u00a0<\/span>(888-682- 6562<\/span><\/a>)<\/span><\/p>\n www.medicalmarijuanainc.com<\/span><\/a><\/p>\n www.facebook.com\/mjnainc<\/span><\/a><\/p>\n \u00a0<\/span><\/p>\n Investor Relations Contact:<\/b><\/p>\n EquiNet, LLC<\/span><\/p>\n Toll Free:\u00a0<\/span>(877) 964.6463<\/span><\/a><\/p>\n Office\/Direct:\u00a0(858) 264-6500<\/span><\/p>\n Email:\u00a0<\/span>info@equinet.us<\/span><\/a><\/p>\n
\n<\/span><\/p>\n